NCT06857409

Brief Summary

Chronic shoulder pain affects quality of life and is often associated with central sensitization, leading to treatment resistance. Pulsed radiofrequency (PRF) of the suprascapular nerve, which innervates 70% of the shoulder joint, is a promising therapy for nociceptive and neuropathic pain. This study evaluates the effects of PRF on central sensitization and neuropathic pain in chronic shoulder pain. Clinical assessments will be conducted at baseline, 1 month, and 3 months post-treatment to determine PRF's potential in reducing central sensitization and improving shoulder function.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

February 27, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 4, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2026

Completed
Last Updated

May 8, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

February 27, 2025

Last Update Submit

May 7, 2026

Conditions

Keywords

shoulder painsuprascapular nerveradiofrequencycentral sensitizationneuropatic pain

Outcome Measures

Primary Outcomes (1)

  • Central Sensitization Inventory (CSI)

    The CSI will be used to assess symptoms related to CS. The CSI will consist of two parts, Part A and Part B. Part A will include 25 items scored on a scale from 0 to 100, with higher scores indicating an increased CS-related symptom burden. In Part B, diagnoses of central sensitivity syndromes will be questioned, and this part will not be included in the scoring.

    baseline, 1st and 3rd months

Secondary Outcomes (3)

  • Douleur Neuropathique 4 (DN4) Questionnaire

    baseline, 1st and 3rd months

  • Numerical Rating Scale (NRS)

    baseline, 1st and 3rd months

  • Shoulder Pain and Disability Index (SPADI)

    baseline, 1st and 3rd months

Study Arms (1)

suprascapular nerve pulsed radiofrequency

patients undergoing suprascapular nerve pulsed radiofrequency therapy

Procedure: pulsed radiofrequency

Interventions

All patients will be monitored with electrocardiography, non-invasive blood pressure, and peripheral oxygen saturation, and peripheral intravenous vascular access will be performed before the procedure. Patients will be placed in a sitting position. The physician will stand behind the patient for the posterior approach. The skin area to be injected will be prepared and covered in a sterile manner using a povidone-iodine-based solution. The operator will use ultrasound (a TOSHIBA Aplio 500 Ultrasound) guidance to perform suprascapular nerve radiofrequency. The suprascapular notch will be visualized. A twenty-two gauge, 10 cm long, and 10 mm active-tipped radiofrequency cannula will be introduced to the suprascapular notch. Motor stimulation will be performed at 2 Hz at a setting of 1 V, and sensory stimulation will be performed at 50 Hz at a setting of 0.5 V. After the needle tip confirmation, pulsed radiofrequency will be applied to the suprascapular nerve for 360 seconds.

suprascapular nerve pulsed radiofrequency

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Chronic shoulder pain persisting for at least 3 months

You may qualify if:

  • Chronic shoulder pain persisting for at least 3 months
  • Radiologically confirmed shoulder lesions, including:
  • Rotator cuff tendinopathy Adhesive capsulitis Bursitis Osteoarthritis
  • At least two positive provocation tests (Neer, Hawkins, Jobe tests)
  • Shoulder pain resistant to conservative treatments, including:
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) Physical therapy Corticosteroid injections

You may not qualify if:

  • Traumatic shoulder pain (e.g., fractures, dislocations)
  • History of shoulder surgery
  • Active inflammation or rheumatic diseases affecting the shoulder, including:
  • Rheumatoid arthritis Polymyalgia rheumatica Ankylosing spondylitis
  • Cervical radiculopathy
  • Central nervous system diseases, such as:
  • Multiple sclerosis Stroke Spinal cord injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Shoulder Pain

Interventions

Pulsed Radiofrequency Treatment

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRadiofrequency TherapyRehabilitation

Study Officials

  • ERKAN YAVUZ AKÇABOY, Prof. Dr.

    Ankara City Hospital Bilkent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

February 27, 2025

First Posted

March 4, 2025

Study Start

February 27, 2025

Primary Completion

October 1, 2025

Study Completion

May 5, 2026

Last Updated

May 8, 2026

Record last verified: 2026-02

Locations